Intrepid Financial Planning Group’s Actinium Pharmaceuticals ATNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Sell |
12,500
-2,000
| -14% | -$2.8K | 0.01% | 122 |
|
|
2025
Q1 | $23.3K | Buy |
14,500
+500
| +4% | +$805 | 0.01% | 117 |
|
|
2024
Q4 | $17.6K | Sell |
14,000
-5,000
| -26% | -$6.3K | 0.01% | 121 |
|
|
2024
Q3 | $35.7K | Sell |
19,000
-1,000
| -5% | -$1.88K | 0.02% | 125 |
|
|
2024
Q2 | $148K | Buy |
20,000
+4,000
| +25% | +$29.6K | 0.06% | 118 |
|
|
2024
Q1 | $125K | Hold |
16,000
| – | – | 0.05% | 119 |
|
|
2023
Q4 | $81.3K | Sell |
16,000
-2,000
| -11% | -$10.2K | 0.04% | 117 |
|
|
2023
Q3 | $107K | Hold |
18,000
| – | – | 0.06% | 112 |
|
|
2023
Q2 | $134K | Sell |
18,000
-1,000
| -5% | -$7.42K | 0.06% | 113 |
|
|
2023
Q1 | $180K | Sell |
19,000
-1,000
| -5% | -$9.45K | 0.09% | 109 |
|
|
2022
Q4 | $213K | Hold |
20,000
| – | – | 0.12% | 96 |
|
|
2022
Q3 | $148K | Hold |
20,000
| – | – | 0.08% | 96 |
|
|
2022
Q2 | $96K | Buy |
+20,000
| New | +$96K | 0.05% | 103 |
|